These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 38193092)

  • 21. The Role of MicroRNAs in Repair Processes in Multiple Sclerosis.
    Duffy CP; McCoy CE
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microRNA-92a-3p in colorectal cancer: a review.
    Yamada NO; Senda T
    Med Mol Morphol; 2021 Sep; 54(3):193-202. PubMed ID: 33620640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is It worth Considering Circulating microRNAs in Multiple Sclerosis?
    Jagot F; Davoust N
    Front Immunol; 2016; 7():129. PubMed ID: 27092141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The potential role of mirnas in the pathogenesis of hemorrhagic fever with renal syndrome].
    Gareev IF; Beylerli OA; Pavlov VN; Izmailov AA; Khusnutdinova EK; Khasanova GM; Gilyazova IR; Khasanova AN; Guoqing Wang GW; Honglan Huang HH; Jiahui Pan JP; Tong Shao TS; Haochen Yao HY; Wenfang Wang WW; Khasanov DN
    Urologiia; 2021 Mar; (1):112-119. PubMed ID: 33818946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating microRNAs as potential biomarkers in myasthenia gravis patients.
    Punga AR; Punga T
    Ann N Y Acad Sci; 2018 Jan; 1412(1):33-40. PubMed ID: 29125182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression, regulation and function of microRNAs in multiple sclerosis.
    Ma X; Zhou J; Zhong Y; Jiang L; Mu P; Li Y; Singh N; Nagarkatti M; Nagarkatti P
    Int J Med Sci; 2014; 11(8):810-8. PubMed ID: 24936144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and prognostic potential of circulating miRNAs for intracranial aneurysms.
    Gareev I; Beylerli O; Yang G; Izmailov A; Shi H; Sun J; Zhao B; Liu B; Zhao S
    Neurosurg Rev; 2021 Aug; 44(4):2025-2039. PubMed ID: 33094424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The blood-brain barrier in multiple sclerosis: microRNAs as key regulators.
    Kamphuis WW; Derada Troletti C; Reijerkerk A; Romero IA; de Vries HE
    CNS Neurol Disord Drug Targets; 2015; 14(2):157-67. PubMed ID: 25613507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNAs Participate in MS Pathological Processes and Its Therapeutic Response.
    Wu T; Chen G
    Mediators Inflamm; 2016; 2016():4578230. PubMed ID: 27073296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current state of MiRNAs as biomarkers and therapeutic tools.
    Gareev I; Beylerli O; Yang G; Sun J; Pavlov V; Izmailov A; Shi H; Zhao S
    Clin Exp Med; 2020 Aug; 20(3):349-359. PubMed ID: 32399814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential microRNA expression in blood in multiple sclerosis.
    Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The circulating miRNAs as diagnostic and prognostic markers.
    Terrinoni A; Calabrese C; Basso D; Aita A; Caporali S; Plebani M; Bernardini S
    Clin Chem Lab Med; 2019 Jun; 57(7):932-953. PubMed ID: 30838832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [microRNA and internal medicine: from pathophysiology to the new diagnostic and therapeutic procedures].
    Novak J; Souček M
    Vnitr Lek; 2016; 62(6):477-85. PubMed ID: 27485847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases.
    Mirzaei R; Zamani F; Hajibaba M; Rasouli-Saravani A; Noroozbeygi M; Gorgani M; Hosseini-Fard SR; Jalalifar S; Ajdarkosh H; Abedi SH; Keyvani H; Karampoor S
    J Neuroimmunol; 2021 Sep; 358():577640. PubMed ID: 34224949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment.
    Jahromi FNA; Dowran R; Jafari R
    Cell Commun Signal; 2023 May; 21(1):88. PubMed ID: 37127640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
    Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
    Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential therapeutic and diagnostic approaches of exosomes in multiple sclerosis pathophysiology.
    Hasaniani N; Nouri S; Shirzad M; Rostami-Mansoor S
    Life Sci; 2024 Jun; 347():122668. PubMed ID: 38670451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing.
    Guerau-de-Arellano M; Alder H; Ozer HG; Lovett-Racke A; Racke MK
    J Neuroimmunol; 2012 Jul; 248(1-2):32-9. PubMed ID: 22078708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases.
    Jin XF; Wu N; Wang L; Li J
    Cell Mol Neurobiol; 2013 Jul; 33(5):601-13. PubMed ID: 23633081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow mesenchymal stem cells to ameliorate experimental autoimmune encephalomyelitis via modifying expression patterns of miRNAs.
    Haghmorad D; Khaleghian A; Eslami M; Sadeghnejad A; Tarahomi M; Yousefi B
    Mol Biol Rep; 2023 Dec; 50(12):9971-9984. PubMed ID: 37897611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.